Printer Friendly

Dartmouth researchers find arsenic triggers for rare leukemia.

Dartmouth Medical School researchers have identified a new way that arsenite, a form of arsenic, acts in treating a rare cancer known as APL, or acute promyelocytic leukemia.

Their study is published in the Jan. 3 issue of the Journal of the National Cancer Institute.

"We knew that arsenite was particularly effective against this cancer, and we wanted to figure out why," said Sutisak Kitareewan, an author on this paper and an instructor of pharmacology and toxicology at the medical school. "Now we know that arsenite destabilizes lysosomes, a part of a cell that contains certain enzymes, which, when released, often kill APL cells."

APL is caused by the swapping of chromosomes 15 and 17, which forms a fusion protein. This fusion protein prevents certain blood cells from maturing and leads to an accumulation of immature leukemia cells. Researchers found that arsenite causes rapid destabilization of the lysosome in cells, and that breaks the lysosome apart, releasing enzymes that destroy these particular kinds of leukemia cells.

"We hope this finding will be used to inform further research into treating APL," said co-author Ethan Dmitrovsky, professor of medicine and of pharmacology and toxicology, who also is affiliated with the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center. "We also hope that further studies examine if this same mode of action is the basis for arsenic toxicity."

In addition to Kitareewan and Dmitrovsky, other authors on the paper include B.D. Roebuck, professor of pharmacology and toxicology; Eugene Demidenko, research professor of community and family medicine in the area of biostatistics; and Roger Sloboda, the Ira Allen Eastman Professor of Biological Sciences. Dmitrovsky also holds the Andrew G. Wallace Professorship at Dartmouth.
COPYRIGHT 2007 Business Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RESOURCES: health; treatment for acute promyelocytic leukemia
Publication:New Hampshire Business Review
Article Type:Brief article
Geographic Code:1USA
Date:Jan 19, 2007
Previous Article:Cigna to offer HSAs to smaller employers.
Next Article:Sununu seeks permanent ban on Internet taxes.

Related Articles
Helping cancers mature so they might die.
Arsenic: a novel cancer remedy?
New Drug Thwarts a Chronic Leukemia.
Cell Therapeutics TRISENOX granted European authorization.
Blood vessel poisoning: arsenic narrows artery that feeds brain. (This Week).
Arsenic helps tumors, blood vessels grow.
Funky chicken.
Bacteria found to release arsenic into groundwater.
West Bengal & Bangladesh Arsenic Crisis Information Center.
Arsenic in U.S. rice.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters